Simhal, Anish K. http://orcid.org/0000-0001-7848-3565
Maclachlan, Kylee H. http://orcid.org/0000-0001-7873-4854
Elkin, Rena
Zhu, Jiening
Norton, Larry
Deasy, Joseph O.
Oh, Jung Hun
Usmani, Saad Z. http://orcid.org/0000-0002-5484-8731
Tannenbaum, Allen
Funding for this research was provided by:
American Society of Hematology
Multiple Myeloma Research Foundation
Royal Australasian College of Physicians
Breast Cancer Research Foundation
Leukemia Lymphoma Society; International Myeloma Society
Article History
Received: 5 April 2023
Revised: 11 October 2023
Accepted: 24 October 2023
First Online: 30 November 2023
Competing interests
: SZU: Research funding: Amgen, BMS/Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, Takeda. Consulting/Advisory Board: Abbvie, Amgen, BMS, Celgene, Genentech, Gilead, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, TeneoBio.